Laila Woc-Colburn is an Infectious Disease physician. OpenAlex indexes 93 publications with 2,317 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1790 Dryden Road
Ms:bcm620, Ste 06.12
Houston, TX 77030
Telephone
713-798-4211Provider last certified this registry record 6 Nov 2023.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ortho-Clinical Diagnostics, Inc.Program year20242 payments
- Gilead Sciences, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
88.9%Cephalosporin Antibacterial20.6%Ceftriaxone65%Cefazolin Sodium18%Cefepime Hcl10%Ceftazidime7%Part D<11 patientsTetracycline-class Drug14.4%Doxycycline Hyclate100%Part D≥53 patients+ 13 more classes in this area
Cardiovascular
5.2%Statin1.2%Atorvastatin Calcium100%Part D<11 patientsBile Acid Sequestrant1.1%Colesevelam Hcl100%Part D<11 patients+ 3 more classes in this area
Nervous system
3.2%Gabapentinoids1.3%Gabapentin100%Part D<11 patientsNonsteroidal Anti-inflammatory Drug0.9%Meloxicam100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Concerns on H5N1 avian influenza given the outbreak in U.S. dairy cattle
The Lancet Regional Health - Americas
2024 - The effect of a plasma next-generation sequencing test on antimicrobial management in immunocompetent and immunocompromised patients—A single-center retrospective study
Antimicrobial Stewardship & Healthcare Epidemiology
2023 - Clinical Characteristics and Outcomes of Chagas Disease in the United States: A Multicenter Retrospective Analysis
American Journal of Tropical Medicine and Hygiene
2023 - Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club
Clinical Infectious Diseases
2022
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”